University of Washington Health Sciences Research Studies Seeking Volunteers

6 item(s) returned.
To access detailed information about a study, click on the study #.

Specific Diseases or Conditions
Study #	Title
20061195	A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Single-agent Tarceva® (erlotinib) Following Complete Tumor resection with or without Adjuvant Chemotherapy in Patients with Stage IB-IIIA Non-small Cell Lung Carcinoma who have EGFR-positive Tumors
6137	A Phase II Study of Intermittent Gleevec® (Imatinib mesylate) and Weekly Paclitaxel in Patients Aged 70 or Older with Advanced Non-Small Cell Lung Cancer
6228	Early Positron Emission Tomography as a Predictor of Response in Neoadjuvant Chemotherapy for Non-Small Cell Lung Cancer
6566	FDG-PET Based Chemotherapy Selection for Metastatic Non-Small Cell Lung Cancer
6600	Phase I/II Clinical Trial Evaluating the Use of Vorinostat Combined with Paclitaxel and Radiotherapy in Patients with Inoperable Stage III Non-Small Cell Lung Cancer Unable to Tolerate Cisplatin
20062200	Registration Phase III Study of Lucanix™ (Belagenpumatucel-L) in Advanced Non-small Cell Lung Cancer: An International Multicenter, Randomized, Double-blinded, Placebo-Controlled Study of Lucanix™ Maintenance Therapy for Stages III/IV NSCLC Subjects Who Have Responded to or Have Stable Disease Following One Regimen of Front-line, Platinum-based Combination Chemotherapy